Genetic polymorphism of cytochrome P4501A1, microsomal epoxide hydrolase, and glutathione S-transferases M1 and T1 in Zimbabweans and Venda of Southern Africa

Pharmacogenetics

Volumn 8, Issue 1, 1998, Pages 83-85

  Masimirembwa, Collen M ^a   Dandara, Collet ^a   Sommers, De K ^b   Snyman, J R ^b   Hasler, Julia A ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Polymorphism; Venda; Xenobiotic metabolizing enzymes; Zimbabwe

Indexed keywords

CYTOCHROME P450 ISOENZYME; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; XENOBIOTIC AGENT;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC DIFFERENCE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PHARMACOGENETICS; POPULATION; PREVALENCE; PRIORITY JOURNAL; SAMPLE; SOUTH AFRICA; XENOBIOTIC METABOLISM; ZIMBABWE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; CYTOCHROME P-450 CYP1A1; EPOXIDE HYDROLASES; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MICROSOMES; MUTATION; POLYMORPHISM, GENETIC; SOUTH AFRICA; VARIATION (GENETICS); ZIMBABWE;

EID: 0031932575     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199802000-00011     Document Type: Article

References (15)

1. Brockmöller J, Gross D, Kerb R, Drakoulis N, Roots I. Correlation between trans-stilbene oxide-glutathione conjugation activity and deletion mutation in the glutathione S-transferase class mu gene detected by polymerase chain reaction. Biochem Pharmacol 1992; 43, 647-650.
2. Chen CL, Liu Q, Relling MV. Simultaneous characterisation of glutathione S-transferase M1 and T1 polymorphism by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996; 6, 187-191.
3. Daly AK, Cholerton S, Armstrong M, Idle JR. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspect 1994; 102, 55-61.
4. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994; 3, 421-128.
5. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer associated MspI polymorphism with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem 1991; 110, 407-411.
6. Hayashi S, Watanabe J, Kawajiri K. High susceptibility to lung cancer analysed in terms of combined genotypes of P4501A1 and Muclass Glutathione S-transferase genes. Jpn J Cancer Res 1992; 83, 866-870.
7. Hirvonen A, Husgafvel-Pursiainen, Karjalainen A, Anttila S, Vainio H. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Can Epidemiol Biomarkers Prev 1992; 1, 485-489.
8. Kalow W, Bertillson L. Interethnic factors affecting drug response. Adv Drug Res 1994; 25, 1-50.
9. Lee EJD, Wong JYY, Yeoh PN, Gong NH. Glutathione S-transferase theta (GSTT1) genetic polymorphism among Chinese, Malays and Indians in Singapore. Pharmacogenetics 1995; 5, 332-334.
10. London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, Calfornia. J National Cancer Inst 1995; 87, 1246-1254.
11. McGlynn K, Hu Y, Clapper ML, Zhou T, Wild CP, Xia X-L, Baffoe-Bonnie A, Ofori-Adjei, Chen G-C, London WT et al. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA 1995; 92, 2384-2387.
12. Nebert DW, McKinnon RA, Puga A. Human drug-metabolising enzyme polymorphism: Effects on risk of toxicity and cancer. DNA Cell Biol 1996; 15, 273-280.
13. Pemble S, Schroeder SR, Spencer SR, Meyer DJ, Haller E, Bolt HM, Ketterer B, Taylor JB. Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterisation of a genetic polymorphism. Biochem J 1994; 300, 271-276.
14. Strange RC. Glutathione S-transferase and cancer susceptibility. In: Vermeulen NPE, Mulder GJ, Nieuwenhuyse H, Peters WHM, Bladeren PJV, eds. Glutathione S-transferases structure, function and clinical implications. London: Taylor and Francis, 1996; 239-247.
15. Zhao L, Alldersea J, Fryer A, Tighe A, Ollier B, Thomson, Jones P, Strange P. Polymorphism at the glutathione S-transferase GSTM1 locus: a study of the frequency of the GSTM1 A. B. A/B and null phenotypes in Nigerians. Clinica Chimica Acta 1994; 225, 85-86.